Haleon plc (NYSE:HLN) Given Average Rating of “Hold” by Analysts

Haleon plc (NYSE:HLNGet Rating) has earned an average rating of “Hold” from the thirteen analysts that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $364.00.

Several equities analysts have commented on HLN shares. Barclays boosted their price target on shares of Haleon from GBX 360 ($4.51) to GBX 364 ($4.56) in a research note on Tuesday, January 31st. Investec began coverage on shares of Haleon in a report on Thursday, February 23rd. They issued a “sell” rating for the company. Sanford C. Bernstein began coverage on shares of Haleon in a report on Tuesday, April 4th. They issued an “outperform” rating for the company. Finally, Argus raised shares of Haleon from a “hold” rating to a “buy” rating in a report on Thursday, April 6th.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. City State Bank acquired a new stake in shares of Haleon in the first quarter valued at approximately $25,000. CoreFirst Bank & Trust acquired a new stake in shares of Haleon in the fourth quarter valued at approximately $26,000. Ahrens Investment Partners LLC acquired a new stake in Haleon during the first quarter worth approximately $27,000. GW&K Investment Management LLC boosted its position in Haleon by 308.4% during the first quarter. GW&K Investment Management LLC now owns 3,529 shares of the company’s stock worth $29,000 after acquiring an additional 2,665 shares during the last quarter. Finally, Resurgent Financial Advisors LLC acquired a new stake in Haleon during the fourth quarter worth approximately $29,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Stock Performance

NYSE:HLN opened at $8.65 on Friday. The company has a fifty day simple moving average of $8.55 and a two-hundred day simple moving average of $7.93. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.62 and a current ratio of 0.93. Haleon has a 52 week low of $5.59 and a 52 week high of $9.05.

Haleon Announces Dividend

The company also recently declared a — dividend, which was paid on Thursday, April 27th. Investors of record on Friday, March 17th were issued a dividend of $0.0577 per share. The ex-dividend date of this dividend was Thursday, March 16th. This represents a yield of 0.7%.

About Haleon

(Get Rating)

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.

Read More

Analyst Recommendations for Haleon (NYSE:HLN)

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.